RDNT - RadNet, Inc.
Bamco Inc. NY acquired a new stake in RadNet, Inc. (NASDAQ: RDNT) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 1,260,992 shares of the medical research company's stock, valued at approximately $77,765,000. Bamco Inc. NY owned about 1.60% of
Oncology Institute (NASDAQ: TOI - Get Free Report) and RadNet (NASDAQ: RDNT - Get Free Report) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Analyst Ratings This is a summary of current ratings
RDNT's advanced imaging mix is expanding. I think this will continue to support its improving revenue quality and margins. RDNT's joint ventures across healthcare systems also help it deepen its integration across customers' workflows. DeepHealth is RDNT's second growth leg, as it pairs external software sales with internal workflow efficiencies.
RadNet tops Q2 estimates as advanced imaging and Digital Health growth accelerate, prompting a higher 2026 Imaging Center outlook.
RadNet, Inc. (NASDAQ: RDNT - Get Free Report)'s stock price rose 6.9% during trading on Monday following a stronger than expected earnings report. The stock traded as high as $74.41 and last traded at $77.4050. Approximately 156,969 shares traded hands during trading, a decline of 81% from the average session volume of 830,771 shares. The stock
RadNet, Inc. (RDNT) Q2 2026 Earnings Call Transcript
RadNet NASDAQ: RDNT reported record quarterly revenue and adjusted EBITDA for the second quarter of 2026, supported by higher imaging volumes, acquisitions, a shift toward advanced imaging procedures and growth in its Digital Health segment.
RadNet (RDNT) is capturing investor attention as its shares surged following a robust Q2 earnings report. The diagnostic imaging company reported an impressive
The headline numbers for RadNet (RDNT) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Total Company Revenue increased 25.0% to a quarterly record of $622.7 million in the second quarter of 2026 from $498.2 million in the second quarter of 2025 Revenue from the Digital Health reportable segment (inclusive of intersegment revenue) increased 56.5% to a quarterly record of $32.4 million in the second quarter of 2026 from $20.7 million in the second quarter of 2025; Annual Recurring Revenue ( 4) (ARR) increased from $53.5 million at June 30, 2025 to $105.5 million at June 30, 2026 and sequentially increased from $96.9 million at March 31, 2026 Total Company Adjusted EBITDA ( 1) was a quarterly record of $99.7 million in the second quarter of 2026 as compared with $81.2 million in the second quarter of 2025, an increase of 22.7%; Digital Health reportable segment Adjusted EBITDA ( 1) was $2.5 million in the second quarter of 2026 compared with $3.4 million in the second quarter of 2025, the result of continued infrastructure investments to fuel growth Imaging Center Segment Adjusted EBITDA ( 1) margin increased by 17 basis points to 16.1% in the second quarter of 2026 from 16.0% in the second quarter of 2025 Adjusting for unusual or one-time items, Adjusted Earnings ( 3) was $23.2 million and Adjusted Earnings Per Share ( 3) was $0.29 for the second quarter of 2026 as compared with Adjusted Earnings ( 3) of $25.7 million and Adjusted Earnings Per Share ( 3) of $0.34 for the second quarter of 2025 As a percentage of total procedural volumes, advanced imaging increased by 238 basis points to 29.9% in the second quarter of 2026 from 27.5% in the second quarter of 2025 In the second quarter of 2026, aggregate advanced imaging (MRI, CT and PET/CT) procedural volumes increased 21.2% and same-center advanced imaging procedural volumes increased 9.6% as compared with the second quarter of 2025 As of June 30, 2026, balance sheet cash was $726.3 million and Net Debt to Adjusted EBITDA ( 1) Ratio ( 5 ) was 1.8x RadNet revises full-year 2026 Imaging Center guidance levels with increases to Revenue, Adjusted EBITDA ( 1) and Free Cash Flow ( 2 ) and reaffirms all Digital Health guidance ranges LOS ANGELES, Aug. 09, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet” or the “Company”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 442 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2026. Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, “The Imaging Center and Digital Health reportable operating segments continue to demonstrate strong growth and achieve record quarterly results.
Besides Wall Street's top-and-bottom-line estimates for RadNet (RDNT), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2026.
SOMERVILLE, Mass., July 30, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today announced FDA 510(k) clearance for DeepHealth Breast Ultrasound,1 an AI-powered solution that brings greater standardization, clinical accuracy and efficiency to breast ultrasound imaging.
Tom Yeung here with your Sunday Digest . In the 2010s, getting acquired was the ultimate startup status symbol.
LOS ANGELES, July 22, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers and digital health solutions, announced today that it will host a conference call to discuss its second quarter 2026 financial results on Monday, August 10, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
Bessemer Group Inc. grew its holdings in shares of RadNet, Inc. (NASDAQ: RDNT) by 11.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 550,172 shares of the medical research company's stock after purchasing an additional 56,173 shares during the quarter. Bessemer
RadNet's DeepHealth gains FDA clearances for AI breast imaging tools that assess cardiovascular risk and compare prior mammograms.
SOMERVILLE, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- DeepHealth, Inc., a leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), announces it has received FDA 510(k) clearances for two new Breast Suite1 functionalities: Breast Arterial Calcification (BAC) Assessment, a tool applied to standard screening mammograms that automatically identifies breast arterial calcifications, a potential early indicator of cardiovascular disease;2 Prior exam integration into ProFound Pro, which enables automatic processing of prior and current studies to track prior lesions and distinguish new lesions, with the goal of improving cancer detection rates and reducing recalls.
On June 22, 2026, RadNet Inc (RDNT) shares rose 3.8% today, trading at $55.74. The stock has experienced a 52-week range of $50.76 to $85.84, reflecting volatil
On June 10, 2026, RadNet Inc (RDNT) shares rose 3.5% today, trading at $58.16. The stock has seen a 52-week range between $50.76 and $85.84, indicating signific
LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT) (“RadNet”), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of outpatient imaging centers and a premier developer of radiology digital health solutions, today announced that it has entered into Incremental Amendment No. 3 (the “Third Amendment”) to its Third Amended and Restated First Lien Credit and Guaranty Agreement, as amended (the “Existing Credit Agreement” and, as amended by the Third Amendment, the “Credit Agreement”).